Pharma: Other News To Note
Friday, November 30, 2012
Ranbaxy Inc., of Gurgaon, India, initiated a voluntary recall of 41 affected lots of atorvastatin calcium tablets as a precautionary measure due to the fact that the firm said it cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.